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Historically, patients with sports-related concussion (SRC) have been managed in a uni-
form fashion consisting mostly of prescribed physical and cognitive rest with the expec-
tation that all symptoms will spontaneously resolve with time. Although this approach 
will result in successful return to school and sports activities in the majority of athletes, 
an important proportion will develop persistent concussion symptoms characteristic of 
post-concussion syndrome (PCS). Recent advances in exercise science, neuroimaging, 
and clinical research suggest that the clinical manifestations of PCS are mediated by 
unique pathophysiological processes that can be identified by features of the clinical 
history and physical examination as well as the use of graded aerobic treadmill testing. 
Athletes who develop PCS represent a unique population whose care must be individu-
alized and must incorporate a rehabilitative strategy that promotes enhanced recovery of 
concussion-related symptoms while preventing physical deconditioning. In this review, 
we present our evolving evidence-based approach to evaluation and management of 
athletes with PCS that aims to identify the pathophysiological mechanisms mediating 
persistent concussion symptoms and guides the initiation of individually tailored rehabil-
itation programs that target these processes. In addition, we outline the important qual-
ified roles that multi-disciplinary healthcare professionals can play in the management of 
this patient population, and discuss where future research efforts must be focused to 
further evaluate this evolving pathophysiological approach.
Keywords: sports-related concussion, post-concussion syndrome, athlete, multi-disciplinary, management, 
treatment
BaCKGroUnd
Over the past 10–15 years, clinical studies have established sports-related concussion (SRC) as a form 
of traumatic brain injury (TBI) that results in temporary alterations in neurological and neurocogni-
tive functioning that typically recover within 1–2 weeks post-injury (1–4). In a subset of adult and 
pediatric SRC patients, however, conservative management will fail to result in clinical recovery 
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and patients will develop prolonged symptoms characteristic 
of post-concussion syndrome (PCS). Historically, PCS patients 
were managed clinically with the assumption that persistent 
concussion symptoms were representative of an ongoing global 
metabolic brain injury that required additional amounts of 
cognitive and physical rest (5, 6). While this approach may lead 
to symptom resolution in a small proportion of these patients, 
it is inappropriate for athletes and does not take into account 
the pathophysiological processes that govern the heterogeneous 
clinical manifestations of PCS.
To address these limitations, emerging clinical and laboratory 
research suggests that features of the clinical history and physical 
examination, along with the use of supplementary tests such as 
graded aerobic treadmill testing, can be used to provide a view 
into unique pathophysiological mechanisms responsible for 
the persistent symptoms of PCS and help guide the initiation 
of targeted rehabilitative therapies leading to enhanced clinical 
recovery and successful return to sports (7–11). Although pre-
vious reports have examined treatment options for patients 
with concussion (12–14), a comprehensive evidence-based 
pathophysiology-based treatment approach to direct multi-
disciplinary management of PCS in athletes is lacking.
Accordingly, we present here an evolving clinical approach to 
athletes with PCS that focuses on early identification and targeted 
treatment of the pathophysiological mechanisms governing 
persistent concussion symptoms. This report also outlines the 
qualified roles and responsibilities of healthcare professionals 
that can help contribute to the multi-disciplinary management of 
this unique patient population.
tHe natUraL History oF  
sports-reLated ConCUssion
In order to properly manage athletes with PCS, physicians must 
have an understanding of the natural history of SRC and the 
clinical factors associated with prolonged recovery and the devel-
opment of PCS. Despite receiving enormous research attention 
over the past two decades, our understanding of what constitutes 
a normal clinical recovery following SRC continues to evolve. 
At present, expert opinion supports the understanding that SRC 
is a self-limiting condition that presents with symptoms and 
alterations in neurocognitive and neurological functioning that 
typically resolve within 7–10  days with proper return-to-learn 
and return-to-play management (3). This opinion is supported by 
epidemiological studies and systematic reviews performed largely 
in collegiate athletes that document symptom recovery as well 
as normalization of selected balance and neurocognitive scores 
within this short time frame (1, 15, 16). The proportion of adult 
athletes that experience persistent symptoms beyond this period 
varies in the literature from 10 to 30% (12). In contrast to collegiate 
and professional athletes, there is some evidence to suggest that 
child and adolescent athletes take longer to return to their neu-
rological baseline following SRC. A recent systematic review and 
meta-analysis concluded that high school athletes demonstrate 
neurocognitive recovery within 7 days and symptomatic recovery 
within 15 days post-injury (4). These figures likely represent the 
true natural history of SRC; however, longer  recovery times are 
commonly observed among patients who present to pediatric 
 tertiary concussion clinics, where median lengths of recovery 
range from 25 to 75  days and 43–73% of patients experience 
symptoms lasting greater than 4 weeks (17–19).
Given our evolving understanding of what constitutes a nor-
mal recovery following SRC, predicting how long it will take for 
patients to recover and determining which patients are at risk of 
developing PCS represent significant clinical challenges. Clinical 
variables associated with prolonged recovery and the development 
of PCS vary across studies but may include younger age, female 
sex, loss of consciousness or post-traumatic amnesia at the time 
of injury, a previous history of concussion, ADHD and mood dis-
orders, initial headache or dizziness at the time of injury, delayed 
symptom onset, and initial symptom burden (2, 18, 20–28). 
In addition to these clinical factors, emerging work also suggests 
that pre-injury psychological factors such as somatization (29) 
and resilience (30) may also impact post-injury functioning. 
Although an appreciation of these clinical factors may aid physi-
cians in their ability to provide anticipatory guidance to patients 
and their parents (31), more recent research has focused on 
identifying clinical biomarkers that reflect the pathophysiological 
processes governing persistent symptoms. For instance, emerging 
evidence suggests that patients who present with subjective and 
objective evidence of vestibulo-ocular dysfunction take twice as 
long to recover compared with those without these findings and 
are more likely to develop PCS (19).1 Likewise, acute concussion 
patients who demonstrate significant exercise intolerance on 
graded aerobic treadmill testing take longer to recover than those 
with less exercise intolerance (Leddy et al., unpublished data).
Taken together, the vast majority of pediatric and adult SRC 
patients will achieve a complete neurological recovery and 
return to full school and sports activities within weeks of injury. 
However, those that experience persistent symptoms will benefit 
from early identification and further multi-disciplinary assess-
ment by a team of experts with clinical training in TBI.
deFininG post-ConCUssion 
syndroMe in atHLetes
One of the obstacles to evaluating the effect of PCS on patient 
outcomes and deciding when to initiate treatment in SRC patients 
is the lack of a universal clinically accepted definition for PCS. At 
present, the two standardized definitions of PCS have shortcom-
ings that limit their application to clinical practice. The Diagnostic 
and Statistics Manual (DSM-IV) defines PCS as: (1) cognitive 
deficits in attention or memory and; (2) at least three or more 
symptoms including; headache, dizziness, fatigue, irritability, 
apathy, personality change, or sleep or affective disturbance (32). 
To meet the DSM criteria for PCS, symptoms must be present 
for three months or greater. In comparison, the World Health 
1 Ellis M, Cordingley D, Vis S, Reimer K, Leiter J, Russell K. Clinical predictors of 
vestibulo-ocular dysfunction in pediatric sports-related concussion. J Neurosurg 
Pediatr (Forthcoming). 
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Organization’s International Classification of Diseases (ICD-10) 
defines PCS as the presence of three or more of the following 
symptoms that must be present within the first month post-injury 
including: headache, dizziness, fatigue, irritability, insomnia, and 
concentration or memory difficulty. One of the well acknowl-
edged limitations of the existing definitions of PCS is their poor 
specificity and their inclusion of symptoms that are frequently 
experienced by patients with other neurological disorders such as 
depression and migraine as well healthy children and adolescents 
during everyday life (33, 34). Studies suggest that there is little 
agreement between these definitions in clinical practice (35) and 
that the ICD-10 definition is six times more sensitive than the 
DSM definition (32). In addition to these standardized definitions, 
other non-standardized definitions such as prolonged symptoms 
or recovery (symptoms lasting greater than 7–28 days) (2, 23), 
persistent postconcussion symptoms (36), and delayed symptom 
resolution (37) have also been used to describe PCS patients. Such 
descriptions have not only created confusion in the literature but 
limit comparisons between these studies. Although standardized 
definitions of PCS are important for research purposes, many 
athletes with symptoms persisting weeks after injury will not 
meet these PCS criteria yet experience significant impairments 
in quality of life, including feelings of worry and hopelessness 
regarding the effect of their injury on return to school and sport 
activities. Importantly, many athletes also begin to experience 
aerobic deconditioning within 1–2 weeks of inactivity that can 
also manifest as fatigue, irritability, and sleep disturbance that can 
be difficult to distinguish from symptoms of PCS. Taken together, 
many athletes will not meet any standardized criteria for PCS; 
however, early active rehabilitation should be considered in those 
with symptoms persisting beyond 1.5–2 weeks to avoid aerobic 
deconditioning and help optimize neurological recovery.
patHopHysioLoGy oF aCUte  
srC and pCs
Basic science and neuroimaging research continues to shape our 
understanding of the pathophysiological mechanisms that govern 
clinical symptoms in acute concussion and PCS. Historically, the 
clinical manifestations of concussion were thought to arise pri-
marily as a result of functional disturbances in brain physiology 
rather than a structural brain injury (3). However, recent research 
has begun to challenge this assumption. Animal models of con-
cussion and TBI suggest that the acute phase of injury is primarily 
characterized by an increase in cerebral cellular energy demand 
coupled by insufficient energy substrate delivery resulting in a 
metabolic energy crisis (38). This metabolic mismatch occurs 
during a period in which alterations in neuronal depolarization, 
ion transport, glycolysis, mitochondrial function, and excitatory 
neurotransmitter release are met with reductions in global and 
regional cerebral blood flow (CBF). Although the temporal course 
of these metabolic processes has been well documented in animal 
studies, the magnitude and duration of these pathophysiological 
alterations in humans remain poorly understood. Among the 
secondary brain injury processes that play an important role in 
the pathophysiology of moderate, and severe TBI is ischemia. 
Studies suggest that inadequate CBF delivery during acute TBI is 
an independent risk factor for poor outcome and death (39–42) 
while 90% of fatal TBI patients demonstrate histological evidence 
of ischemia at autopsy (43, 44). That patients often report an 
exacerbation of concussion symptoms with increased physical 
and cognitive exercise suggests that a mismatch between cerebral 
metabolic demand and CBF delivery may potentially mediate 
some of the symptoms of acute SRC and PCS. Recent studies 
using magnetic resonance imaging (MRI)-based quantitative 
CBF sequences have demonstrated global and regional reductions 
in resting CBF in adolescents and collegiate athletes with SRC 
(45–48). Despite these findings, the relationship between exercise 
intolerance and CBF dysregulation in concussion remains poorly 
understood but may be mediated by alterations in autonomic 
nervous system function. Concussion patients have been found 
to demonstrate physiological markers of increased sympathetic 
nervous system output such as higher resting heart rates and 
blood pressure (49). Furthermore, preliminary evidence suggests 
that concussion is associated with CBF dysregulation that is 
mediated through alterations in carbon dioxide sensitivity (50) 
and cerebrovascular reactivity (51–54). Given that mean arterial 
blood pressure and PaCO2 are important mediators of global and 
regional CBF, it is possible that dysfunction within these systems 
is responsible for some of the clinical manifestations of acute SRC 
and PCS.
In addition to functional changes in neurovascular physiol-
ogy, accumulating studies suggest that acute SRC may also be 
associated with microstructural white matter injury. Studies 
using diffusion tensor imaging (DTI) have detected group differ-
ences in several quantitative DTI indices between SRC patients 
and healthy controls (55–57); however, the proportion of SRC 
patients who develop these changes remains unclear as does the 
relationship of these changes to the severity and volume of head 
injuries, underlying neuropathology, as well as clinical outcomes. 
Evidence also suggests that concussion and mTBI are associated 
with the release of proteins such as S100β, glial fibrillary acidic 
protein, tau, and αII-spectrin N-terminal fragment (SNTF) 
(58–62). Although preliminary studies suggest these proteins 
can be readily detected in the peripheral blood and cerebrospinal 
fluid of concussion and mTBI patients, future work is needed 
to establish the clinical utility of these potential biomarkers in 
individual patient management.
While these research advances support the notion that acute 
SRC is mediated by alterations in brain cellular and cerebrovas-
cular physiology, the extent to which these processes mediate the 
clinical manifestations of PCS remains unclear. Clinically, some 
symptoms of PCS appear reflective of a persistent global meta-
bolic brain injury while others point to isolated dysfunction of 
neurological sub-systems or co-existing neurological conditions 
that are multi-factorial in etiology. As such, the initial assessment 
of the athlete with PCS should not be simply aimed at cataloging 
concussion symptoms, but rather combining elements of the 
clinical history and physical examination with results of other 
supplementary tests to elucidate the pathophysiological processes 
that govern persistent symptoms.
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initiaL assessMent
A careful and complete clinical history is perhaps the most 
important component of the initial assessment of athletes with 
PCS and provides important clues that help guide the physical 
examination and aids in the identification of the pathophysiology 
underlying persistent concussion symptoms. Initial injury details 
that are important to elicit from the athlete include the mechanism 
of injury, the presence of loss of consciousness, post-traumatic 
amnesia or seizure; concussion symptoms experienced at the time 
of injury, and initial and subsequent medical management of the 
injury. Pre-existing medical conditions that may impact concus-
sion recovery and symptom duration include a history of previ-
ous concussions, non-specific or migraine headaches, ADHD 
or learning disorders, psychiatric conditions such as depressive 
or anxiety disorders, previous cervical spine injuries, and pre-
existing neuro-ophthalomological conditions such as strabismus 
or convergence insufficiency. A history of other disorders that 
can account for presenting or persisting symptoms and that 
can influence return-to-play decision-making such as a history 
of seizure disorders, structural brain abnormalities (i.e., Chiari 
Malformations, arachnoid cysts), hematological conditions (i.e., 
anemia or platelet disorders), and infectious diseases (i.e., mono-
nucleosis) should also be assessed. Assessment of previous and 
present school and social functioning is also important to help 
gauge the effects of persistent concussion symptoms on cogni-
tive and emotional functioning. A family history of psychiatric 
disorders and migraine headaches may also predispose patients 
to certain post-concussion symptoms or conditions.
In addition to assessing the nature and magnitude of the 
patient’s persistent concussion symptoms, it is also important 
to identify the circumstances, environments, or activities that 
elicit or exacerbate these symptoms. In this way, symptoms that 
are exacerbated by physical exertion point to a persistent global 
metabolic brain injury while those that are not made worse with 
exercise are more likely to result from isolated neurological sub-
system dysfunction or other co-existing conditions. Symptoms 
commonly reported by athletes with PCS include headaches, diz-
ziness, sensitivity to light and sound, difficulty focusing or con-
centrating, sleep disturbance, and fatigue. Because some athletes, 
in particular children, may not have the vocabulary to express 
subtle aspects of their symptoms, it is important that physicians 
ask specifically about fixed or transient neurological deficits such 
as monocular blurred vision or transient weakness or numbness 
that can point to focal injury to central and peripheral nervous 
system structures (63–65).
In order to identify objective impairments responsible 
for persistent concussion symptoms, all PCS patients should 
undergo a complete neurological examination ideally performed 
by an experienced sports medicine physician, neurologist, or 
neurosurgeon. Although standardized concussion assessment 
tools have become available (3, 66), use of these tools in isola-
tion is insufficient to evaluate patients with PCS. The physical 
examination should include assessment of cranial nerve, motor, 
sensory, reflex, cerebellar, gait, and balance testing. In addition, 
a focused vestibulo-ocular examination that includes objective 
testing of convergence, smooth pursuits, saccades, and the 
vestibulo-ocular reflex should be performed (67, 68). All patients 
should undergo a cervical spine examination that includes range 
of motion, palpation, and provocative ligament and cervical diz-
ziness testing. Patients that report monocular visual symptoms 
should undergo careful testing of pupillary function, visual acuity, 
visual fields, color vision, as well as fundoscopy to rule out optic 
nerve or retinal pathology (65). Those that report a history of 
 intermittent vertigo should undergo the Dix-Hallpike maneuver 
to test for benign paroxysmal positional vertigo (BPPV). For a 
more detailed approach to physical examination in concussion 
and PCS patients readers are referred to the following review (69).
sUppLeMentaL testinG
diagnostic imaging
Over the past 10  years, several well-validated clinical decision 
rules have been developed to help guide the judicious use of diag-
nostic imaging in patients with acute traumatic head and cervical 
spine injuries that are evaluated in the emergency room setting 
(70–74). Unfortunately there are no evidence-based guidelines 
to direct the use of neuroimaging in PCS patients. Although cur-
rent expert opinion suggests that clinical neuroimaging studies 
contribute little value to the clinical management of concussion 
patients (3), the presence of abnormal and traumatic structural 
neuroimaging findings detected in PCS patients can have an 
important impact on clinical decision-making in select cases. 
As such, MRI of the brain should be considered in patients with 
abnormal CT findings, worsening or persistent symptoms, focal 
neurological deficits, and seizures but is otherwise not indicated 
in most PCS patients (64, 75). Techniques such as susceptibility-
weighted and gradient echo imaging have been shown to offer 
enhanced detection of micro-hemorrhages over CT and conven-
tional MRI sequences and are important to include in this popu-
lation (76). More recently, advanced neuroimaging techniques 
have been applied to SRC patients including DTI, task-based and 
resting state functional MRI, quantitative CBF sequences, and 
cerebrovascular reactivity mapping (75, 77). Despite broadening 
our understanding of concussion pathophysiology, none of these 
tools are used in the routine clinical management of PCS patients. 
In some athletes presenting with PCS, persistent symptoms can 
be attributable to previously unrecognized structural injury or 
instability of the cervical spine that should be investigated by 
static and dynamic cervical spine x-rays or MRI including STIR 
sequences (63, 78). Patients who are diagnosed with co-existing 
structural spine or spinal cord pathology should be referred to a 
neurosurgeon or orthopedic spine surgeon for further evaluation 
and management.
neuropsychological testing
Post-concussion syndrome patients who report prominent cogni-
tive or emotional symptoms and those who experience deteriora-
tion in school performance or functioning should be considered 
for referral to a clinical neuropsychologist. Despite the widespread 
use of computerized neurocognitive tools to evaluate patients 
with acute concussion, neuropsychological assessment of athletes 
with PCS is best accomplished by the use of multiple test batteries 
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that examine domains such as concentration, memory, attention, 
processing speed, and executive function and are tailored to 
the patient’s persistent symptoms and the time course of injury 
(79). Clinical neuropsychologists are the only health-care profes-
sionals who are equipped with the clinical training, experience, 
and armamentarium of neuropsychological testing instruments 
that can provide comprehensive assessment of neurocognitive 
functioning in this patient population (80). Not only can the 
results of formal neuropsychological testing help to quantify the 
impact of TBI on subtle aspects of brain functioning but they 
are often instrumental in confirming complete neurocognitive 
recovery and helping guide return-to-learn and return-to-play 
decision-making.2 In patients with a history of multiple SRCs or 
who develop PCS and achieve symptomatic recovery, formal neu-
rocognitive testing can reveal persistent alterations in cognitive 
functioning that may in some cases lead the multi-disciplinary 
team to recommend retirement from future contact or collision 
sports (64). Such assessments are also very helpful in developing 
strategies for patients experiencing semi-permanent cognitive 
issues at school or work.
Graded aerobic treadmill testing
Accumulating evidence suggests that graded aerobic treadmill 
testing is a safe, well-tolerated, and reliable tool to evaluate exer-
cise tolerance and classify pediatric and adult SRC patients into 
operational PCS sub-types or disorders (7–9, 11, 80–82). This tool 
is valuable because previous work has demonstrated that evalua-
tion of individual symptoms does not allow concussion patients 
to be appropriately classified into operational PCS sub-types or 
trajectories (82). Using a modified Balke protocol, PCS patients 
perform a standardized incremental aerobic treadmill test (the 
Buffalo Concussion Treadmill Test, BCTT). In this test, patients 
walk on a treadmill at a speed of 3.0–3.3 mph and 0% grade. The 
grade is increased by 1%/min during the first 15 min, after which 
the speed is increased by 0.2–0.4 mph/min. Patients are asked to 
rate their symptoms (using a Likert scale) and perceived exertion 
(using the Borg scale) every minute during testing while they 
undergo continuous heart rate monitoring. The test is terminated 
once a symptom-limited threshold or voluntary exhaustion is 
achieved (8). Because there are numerous medical contraindica-
tions to exercise testing that can exist in athletes, these tests are 
best undertaken by an experienced physical therapist, exercise 
physiologist or kinesiologist under the supervision of a physician 
(11). In general, patients who are asymptomatic or have concus-
sion symptoms at rest and who exhibit an early symptom-limited 
threshold on treadmill testing are diagnosed with physiological 
post-concussion disorder (PCD), a condition initially proposed 
to be mediated by persistent alterations in global metabolic and 
cerebrovascular functioning. Patients who have persistent con-
cussion symptoms that are not exacerbated by treadmill testing 
are diagnosed with either vestibulo-ocular PCD or cervicogenic 
PCD based on clinical evidence of dysfunction within the 
2 Cordingley D, Girardin R, Reimer K, Ritchie L, Leiter J, Russell K, et al. Graded 
aerobic treadmill testing in pediatric sports-related concussion: safety, clinical use, 
and patient outcomes. J Neurosurg Pediatr (Forthcoming). 
vestibulo-ocular and cervical spine neurological sub-systems. 
In our experience, physiological PCD patients typically reach an 
early symptom-limited threshold within 5–15 min of initiating 
treadmill testing. The threshold is defined by a ≥3 point change 
in symptom report on the Likert scale at any point during the test 
when compared with the patient’s pre-test symptom level (typically 
headache, head fullness or dizziness, where a point is given for an 
increase in a symptom and/or appearance of a new symptom). In 
general, those with vestibulo-ocular and cervicogenic PCD are 
able to exercise for 15–25 min without symptom exacerbation. In 
rare cases, patients with vestibulo-ocular and cervicogenic PCD 
can experience mild exacerbation of their symptoms that typi-
cally occurs towards the later stages of exercise when walking at 
higher inclines. In some cases, PCS patients may develop clinical 
features that meet the International Classification of Headache 
Disease 3beta (ICHD-3B) criteria for new or worsening migraine 
headaches (83), while others may develop post-injury psychiatric 
outcomes including mood disorders (84). Although some patients 
will demonstrate symptoms of multiple or overlapping PCDs, the 
following classification system provides a conceptual framework 
that allows physicians to identify the pathophysiological mecha-
nisms that govern persistent concussion symptoms and informs 
the development of individually tailored rehabilitation programs 
(see Tables 1 and 2; Figure 1).
ManaGeMent
physiological post-Concussion disorder
Physiological PCD is a sub-type of PCS that is mediated by a 
persistence of the biochemical, autonomic, and cerebrovascular 
alterations that characterize acute concussion. Preliminary 
evidence to support this hypothesis includes the findings of 
alterations in resting CBF detected in adolescent and collegiate 
athletes that persist beyond symptomatic recovery (45, 47, 48) as 
well as regional alterations in resting CBF and cerebrovascular 
responsiveness observed in adolescents and adults with PCS 
(51–54). In addition, patients with PCS have been found to dem-
onstrate higher heart rates at rest (49, 85, 86) and greater CBF 
during exercise suggestive of imbalances in autonomic nervous 
system activity (50).
Clinically, physiological PCD patients typically present with 
persistent concussion symptoms such as headaches, dizziness, 
fatigue, and sensitivity to light that are exacerbated by physical 
activity and point to a persistent mismatch between the meta-
bolic needs of the injured brain and energy substrate delivery. In 
some cases, these patients are asymptomatic, and symptoms are 
only elicited by physical, and less often, cognitive activity. The 
physical examination of patients with physiological PCD is typi-
cally normal but an elevated resting heart rate may be observed. 
Diagnostically, patients with physiological PCD demonstrate 
evidence of exercise intolerance that is characterized by an early 
symptom-limited threshold on graded aerobic treadmill testing.
The mainstay of treatment for physiological PCD is tailored 
sub-maximal aerobic exercise prescription. Laboratory animal 
studies suggest that there is a therapeutic window during 
which time initiation of aerobic exercise can enhance neuro-
logical and neurocognitive recovery through the upregulation 
taBLe 2 | summary of the clinical features, graded treadmill testing results, and treatment recommendations for the main types of headache that occur 
in post-concussion syndrome patients.
physiological pCd Vestibulo-ocular pCd Cervicogenic pCd Migraine
Clinical 
features 
• Mild to moderate, 
global, pounding 
headache at rest that 
is exacerbated by 
reproducible levels 
of physical (and 
sometimes) cognitive 
activity
• Mild to moderate headache 
that is typically absent 
at rest but elicited or 
exacerbated by prolonged 
periods of reading, 
focusing, or time in complex 
visuospatial environments
• Mild to moderate, dull, occipital headache 
that is elicited or exacerbated by activities 
that require prolonged neck stabilization 
or movement
• Moderate or severe, shock-like pain along 
the distribution of the occipital nerves that 
radiates to the top of the head or ears 
and is exacerbated by touch or head and 
neck movements (occipital neuralgia)
• Paroxysmal attacks of unilateral, severe, 
throbbing or pulsating headaches 
associated with photo- and phonophobia, 
nausea, and occasional vomiting
• Provoked by stereotypical stimuli including 
bright lights, stress, dehydration, poor 
sleep, and certain foods.
• Headaches last 4–72 h after which patients 
typically experience headache-free periods
Graded 
treadmill 
testing 
results
• Early symptom-
limited threshold
• Patients typically do 
not experience an early 
symptom-limited threshold
• Patients typically do not experience an 
early symptom-limited threshold
• Patients typically do not experience an early 
symptom-limited threshold
Treatment • Sub-maximal aerobic 
exercise prescription
• Targeted vestibular and 
vision therapy
• Cervical spine manual therapy and 
proprioception re-training
• Headache medications or occipital nerve 
injections (occipital neuralgia) 
• Sub-maximal aerobic exercise prescription
• Prophylactic and abortive headache 
medications
taBLe 1 | summary of proposed pathophysiology, predominant symptoms, physical examination findings, graded treadmill testing results, treatment 
recommendations, important considerations and multi-disciplinary consultations for post-concussion disorders.
physiological pCd Vestibulo-ocular pCd Cervicogenic pCd
Proposed 
pathophysiology
• Persistent alterations in neuronal 
depolarization, cellular metabolism, 
and cerebrovascular physiology
• Isolated dysfunction of central and peripheral 
components of the vestibulo-ocular neurological 
sub-system
• Isolated mechanoceptive, nocioceptive, and 
proprioceptive dysfunction within the cervical 
spine neurological sub-system
Predominant 
symptoms
• Mild to moderate, global, pounding 
headache at rest
• Dizziness, nausea, fatigue, 
drowsiness, light and sound 
sensitivity, irritability
• Symptoms elicited or exacerbated by 
reproducible levels of physical (and 
sometimes) cognitive activity
• Mild to moderate headache and eye strain 
that is typically absent at rest but elicited or 
exacerbated by prolonged periods of reading, 
focusing, or time in complex visuospatial 
environments
• Intermittent blurred vision, diplopia, dizziness, 
fogginess, motion sensitivity, difficulty focusing or 
concentrating
• Intermittent vertigo during certain head positions
• Mild to moderate, dull, occipital headache 
that is elicited or exacerbated by activities 
that require prolonged neck stabilization or 
movement
• Neck pain, stiffness, decreased range of 
motion, dizziness, fogginess, and postural 
imbalance
Physical 
examination 
findings
• Normal physical examination
• Elevated resting heart rate
• Orthostatic changes in pulse and/
or blood pressure accompanied by 
symptoms
• Impaired convergence, accommodation, smooth 
pursuits, saccades, and vestibulo-ocular reflex
• Impaired balance and postural stability testing
• Positive Dix-Hallpike Maneuver (BPPV)
• Decreased cervical lordosis and range of 
motion
• Sub-occipital and paraspinal neck 
tenderness
• Impaired cervical spine proprioception
• Positive cervical dizziness testing
Graded treadmill 
testing results
• Early symptom-limited threshold • Patients typically do not experience an early 
symptom-limited threshold
• Patients typically do not experience an early 
symptom-limited threshold
Treatment • Sub-maximal aerobic exercise 
prescription
• Targeted treatment of co-existing 
vestibulo-ocular dysfunction or 
cervical spine soft tissue injury
• Targeted vestibular and vision therapy
• Otolith repositioning (BPPV)
• Sub-maximal aerobic exercise program to 
maintain aerobic fitness
• Cervical spine manual therapy and 
proprioception re-training
• Gaze and postural stabilization exercises
• Sub-maximal aerobic exercise program to 
maintain aerobic fitness
Important 
considerations
• Patients who do not achieve complete 
recovery with sub-maximal exercise 
prescription should be screened for 
migraine headaches and post-injury 
psychiatric outcomes
• Must rule out co-existing neurological and neuro-
ophthalmological conditions prior to graded 
aerobic treadmill testing and physiotherapy
• Must rule out cervical spine structural injury 
or mechanical instability prior to graded 
aerobic treadmill testing and physiotherapy
Consulting 
multi-disciplinary 
specialists
• Exercise physiologist or kinesiologist • Vestibular physiotherapist
• Neuro-ophthalmologist
• Cervical spine physiotherapist
PCD, post-concussion disorder; BPPV, benign paroxysmal positional vertigo [modified with permission from original source Ellis et al. (9), Taylor & Francis].
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FiGUre 1 | summary of multi-disciplinary pathophysiological approach to athletes with post-concussion syndrome. PCS, post-concussion syndrome; 
PCD, post-concussion disorder; MD, medical doctor [modified with permission from original source (see footnote text 2), Journal of Neurosurgery Publishing Group].
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of brain-derived neuropeptides (87, 88). Clinical studies in both 
pediatric and adult concussion patients have shown a high rate 
of symptom improvement and complete recovery following 
individualized, tailored sub-maximal exercise prescription (see 
footnote text 2, 89, 90). This approach is also supported by one 
randomized controlled study in adolescent mild TBI patients 
with prolonged symptoms who demonstrated improvements 
in concussion symptoms following sub-maximal exercise pre-
scription (91). Preliminary research suggests that neurological 
recovery in physiological PCD may be mediated by improvement 
or normalization of CO2 sensitivity, resting CBF, and cerebrovas-
cular reactivity (50, 53, 54).
Accordingly, physiological PCD patients should be pre-
scribed tailored sub-maximal aerobic exercise programs that 
target 80–90% of the heart rate achieved during graded aerobic 
treadmill testing, once a day for 20  min in duration, 5–6  days 
a week. Patients should undergo follow-up every 1–3 weeks for 
re-assessment at which time the physician may consider repeat 
treadmill testing and modification of the sub-maximal exercise 
prescription or transition into a sports-specific rehabilitation 
program. Importantly, physiological PCD patients may also dem-
onstrate evidence of co-existing vestibulo-ocular dysfunction or 
cervical spine soft tissue injury that can be addressed concurrently 
with targeted rehabilitative strategies. Although, the vast major-
ity of physiological PCD patients will achieve complete recovery 
with sub-maximal exercise prescription, patients who meet the 
ICHD-3B criteria for new or worsening migraine headaches or 
who develop post-injury psychiatric outcomes may experience 
an incomplete response. These patients should be managed on an 
individualized basis in collaboration with an experience headache 
neurologist or psychiatrist as discussed below.
Vestibulo-ocular post-Concussion 
disorder
Vestibulo-ocular PCD is a sub-type of PCS that is mediated by iso-
lated dysfunction of the vestibular and oculomotor sub-systems. 
The oculomotor and vestibular systems are highly integrated 
systems composed of rich interconnections between cortical, 
sub-cortical, brainstem, spinal cord, cerebellar, and peripheral 
sensory organ structures that are responsible for maintaining bal-
ance, postural control, and gaze stability (67, 92). Accumulating 
evidence suggests that clinical features of vestibulo-ocular dys-
function at initial presentation following SRC are associated with 
an increased risk of prolonged recovery and the development 
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of PCS (18, 19, 93). Clinical predictors of vestibulo-ocular 
dysfunction may include female sex, pre-injury depression, and 
post-traumatic amnesia, dizziness, blurred vision, and difficulty 
focusing at the time of injury (see footnote text 1). Patients with 
vestibulo-ocular dysfunction can present with heterogeneous and 
often overlapping deficits that manifest as objective impairments 
in convergence, accommodation, smooth pursuits, saccades, 
the VOR, or BPPV (67, 94). In some cases, objective evidence 
of central and peripheral vestibulo-ocular disorders may not 
be detectable, but patients are found to demonstrate symptom 
provocation on testing potentially pointing to more subtle ves-
tibular pathology (66).
Clinically, vestibulo-ocular PCD patients typically present 
with dizziness, intermittent blurred vision or diplopia, difficulty 
focusing or concentrating, fogginess, motion sensitivity, postural 
imbalance, and headaches that are usually absent at rest but are 
elicited or exacerbated by prolonged periods of reading, focus-
ing, or functioning within complex visuospatial environments. 
Patients with BPPV typically present with intermittent episodes of 
vertigo that are elicited by certain positions such as lying down or 
bending over. A comprehensive physical examination performed 
by a physician with training in TBI and neuro-ophthalmology 
(sports medicine physician, neurologist, neurosurgeon, and 
neuro-ophthalmologist) is especially important in this popula-
tion. To evaluate the need for targeted rehabilitation in vestibulo-
ocular PCD patients, physicians must rule out other structural 
or neurological conditions that can present with persistent 
visual disturbance (such as traumatic cranial nerve injury, retinal 
detachment, demyelinating disease etc.) and ensure that the 
patient’s subjective vestibulo-ocular complaints are attributable 
to objective findings on neuro-ophthalmological examination. 
Accordingly, the neuro-ophthalmological examination of PCS 
patients presenting with persistent visual disturbance should 
include testing of pupillary function, visual acuity, visual fields, 
resting ocular alignment, convergence, extra-ocular movements 
and smooth pursuits, saccades and the vestibulo-ocular reflex. 
The Dix-Hallpike maneuver should be completed in patients with 
vertigo and suspicion of BPPV. Although some abbreviated tools 
such as the vestibular oculomotor (VOMS) tool (66) may help 
identify patients with vestibulo-ocular dysfunction, there are 
indeed SRC patients that do not experience symptom provoca-
tion with these tests but do demonstrate objective findings that 
point to isolated vestibular pathology (i.e., VOR impairments). 
Patients with suspected cranial neuropathies or retinal pathology 
should undergo urgent referral to a neuro-ophthalmologist for 
more comprehensive evaluation. Previous neuroimaging studies 
should also be reviewed for intracranial findings (i.e., orbital 
or temporal bone abnormalities) that can contribute to visual 
or vestibular pathology. Diagnostically, patients with vestibulo-
ocular PCD will present with subjective and objective evidence 
of vestibulo-ocular dysfunction but do not experience an early 
symptom-limited threshold on graded aerobic treadmill testing.
The treatment of vestibulo-ocular PCD must be individualized 
and aimed at rehabilitating the objective deficits and patho-
physiological mechanisms underlying persistent symptoms. 
The principle goal of vestibular physiotherapy is to re-establish 
effective integration of the visual, vestibular, and somatosensory 
systems through a patient-tailored progressive vestibular exercise 
program (95). Specialized care of these patients should ideally 
be carried out by an experienced physiotherapist with advanced 
competency-based clinical training in post-traumatic central 
and peripheral vestibulopathies. To date, there is some empirical 
evidence to support improved outcomes in concussion patients 
treated with vestibular physiotherapy. For example, Alsalaheen 
(96) demonstrated improvement in vestibular symptom inven-
tories and outcome measures in concussion patients treated with 
vestibular physiotherapy. Likewise, one randomized controlled 
trial in patients with SRC demonstrated enhanced recovery among 
those treated with cervicovestibular physiotherapy compared to 
a control group (97). In vestibulo-ocular PCD patients, whose 
symptoms are attributed to peripheral vestibular disorders, evi-
dence can be taken from the general vestibular literature to direct 
treatment in these patients. As such, there is strong evidence to 
support the use of otolith repositioning techniques for patients 
with BPPV (98). There is also moderate to strong clinical evidence 
to support vestibular rehabilitation for patients with vestibular 
hypofunction (99, 100). Although there is low-quality evidence 
to support a clinical benefit of betahistine to treat vertigo and 
dizziness attributable to different vestibular pathologies (101), 
there are no prospective studies that have examined this phar-
macological agent in concussion patients. In recent years, vision 
therapy has received increased attention as a potential therapeutic 
option to treat oculomotor disturbances, such as abnormalities 
of convergence, accommodation, smooth pursuits, and saccades. 
Some studies have reported improved outcomes in patients 
with mild TBI (102) and childhood convergence insufficiency 
(103) with vision therapy; however, there are no prospective 
studies that have examined the clinical benefit of vision therapy 
in concussion patients. Consequently, there remains an urgent 
need for future research to develop evidence-based indications 
for vestibular and vision therapy and evaluate the effect of these 
treatment options on objective findings and outcomes in patients 
with the different clinical manifestations of vestibulo-ocular 
PCD. Because vestibulo-ocular PCD patients do not experience 
an early symptom-limited threshold on graded aerobic treadmill 
testing, these patients should be advised to continue to exercise 
as tolerated to prevent aerobic deconditioning.
Cervicogenic post-Concussion disorder
Cervicogenic PCD is a sub-type of PCS that is mediated by iso-
lated dysfunction of the cervical spine neurological sub-system. 
The cervical spine is the most mobile segment of the spine and 
contains a complex network of muscle and joint mechano-, pro-
prio-, and nocioceptive fibers that transmit important sensory 
information from the cervical spine to the spinal cord, brainstem, 
and cerebellum (104). These interconnections form special-
ized reflexes including the cervicocollic, vestibulocollic, and 
cervico-ocular reflexes that help mediate head, gaze, and neck 
position sense, and stabilization during rapid head movements. 
Biomechanical forces imparted to the brain at the time of SRC can 
also be transmitted to the cervical spine resulting in a whiplash-
type injury and cervicogenic headaches that are mediated by a 
combination of local inflammation, central sensitization, and 
sensory and autonomic pathway dysfunction (105, 106). Trauma 
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or persistent muscle spasm affecting the deep and superficial 
cervical and sub-occipital muscles can also lead to irritation and 
impingement of the sensory nerves that innervate the neck and 
posterior scalp leading to cervicogenic headaches and occasion-
ally occipital neuralgia.
Clinically, cervicogenic PCD patients typically present with 
neck pain and stiffness, fatigue, and fogginess. Dizziness is also 
a common complaint among these patients and is usually absent 
at rest but elicited by activities that require prolonged neck 
stabilization or movement. The headaches described by cervi-
cogenic PCD patients are often occipital in location, can radiate 
to the temples and eyes, and are frequently exacerbated by poor 
posture and neck-related activities such as weight training and 
running. In rare cases, patients can develop occipital neuralgia, 
which is characterized by severe episodes of shock-like pain 
that originate along the distribution of the greater and lesser 
occipital nerves, radiate to the top of the head and ears, and are 
exacerbated by touch or head and neck movements. Common 
physical examination findings include paraspinal and sub-
occipital muscle tenderness and spasm, decreased cervical spine 
range of motion, and dizziness elicited during cervical dizziness 
testing. Tenderness and radiating pain can also often be elicited 
on palpation of the greater and lesser occipital nerves. In some 
cases, supplemental tools such as cervical joint position error can 
be useful to document cervical spine proprioceptive dysfunction. 
Patients that complain of co-existing neurological deficits such as 
upper or lower extremity weakness or numbness and those that 
demonstrate point tenderness on palpation of the central cervical 
spine should be considered for diagnostic imaging to rule out 
structural spinal pathology or instability prior to initiating any 
manual cervical spine rehabilitation (63, 64). Diagnostically, 
cervicogenic PCD patients do not experience an early symptom-
limited threshold on graded aerobic treadmill testing.
The management of cervicogenic PCD is aimed at reduc-
ing local inflammation and muscle spasm, restoring range of 
motion, and re-calibrating communication between the cervical 
spine, vestibular, and oculomotor systems. These objectives are 
best accomplished by a tailored cervical spine rehabilitation 
program undertaken by an experienced physiotherapist that 
includes manual therapy, passive and active range of motion 
exercises, low velocity mobilizations, proprioceptive retraining, 
and exercises to strengthen the deep and superficial cervical 
musculature. Empirical support for this approach is provided by 
one randomized controlled trial demonstrating enhance recovery 
following cervicovestibular physiotherapy in SRC patients (97) 
and observational studies that have demonstrated improvements 
in pain and sensorimotor outcome measures among whiplash 
patients treated with multi-modal cervical spine rehabilitation 
(106–108). In addition, a recent review concluded that reha-
bilitation programs that employ cervical spine mobilization and 
manipulation techniques also provide benefit for cervicogenic 
headaches (109). Patients with severe whiplash-type injuries who 
develop persistent cervicogenic headaches and occipital neural-
gia should be referred to an experienced headache neurologist 
for consideration of pharmacological management and occipital 
nerve injections (110). Because cervicogenic PCD patients do 
not experience an early symptom-limited threshold on graded 
aerobic treadmill testing, these patients should be advised to con-
tinue to exercise as tolerated to prevent aerobic deconditioning.
Migraine Headaches
Although the vast majority of PCS patients will develop headaches 
that fit within the clinical framework of physiological, vestibulo-
ocular, and cervicogenic PCDs, a small but important propor-
tion will develop migraine headaches. Migraine headache is the 
most common primary headache disorder, affecting 15–20% of 
the general population with a peak incidence within the third 
and fourth decades of life (111). This condition has a strong 
hereditary basis with a positive family history frequently noted 
among patients (112). In the authors’ experience, the effect of SRC 
on pre-existing migraine headaches can be highly variable with 
some patients returning to their neurological baseline without 
exacerbation of their migraine headaches and others developing 
worsening migraines that require pharmacological intervention. 
The two most common scenarios that face physicians caring for 
athletes with SRC and migraine headaches are situations in which: 
(1) an athlete with no pre-injury history (but often a positive 
family history) of migraine or non-specific headaches sustains 
a SRC and develops new onset migraine headaches, and (2) an 
athlete with a pre-injury history of migraine headaches develops 
worsening migraine headaches after SRC. In some cases, the 
symptoms of PCS can be difficult to distinguish from migraine; 
however, certain features must be present to meet ICHD-3beta 
criteria for this condition (83). Because of these clinical subtle-
ties, the management of both groups of athletes is ideally carried 
out in collaboration with an experienced headache neurologist. 
In general, migraine headaches are characterized by paroxysmal 
attacks of unilateral, severe, throbbing, or pulsating headaches 
that are frequently accompanied by photo- and phonophobia, 
nausea, and occasional vomiting. These headaches are typically 
provoked by stereotypical stimuli including bright lights, stress, 
dehydration, poor sleep, and certain foods. The headaches can 
last from 4 to 72  h after which patients typically experience 
headache-free periods. These headaches are distinguished from 
those experienced by physiological PCD patients that are typically 
global, pounding headaches that are mild to moderate intensity at 
rest, and along with other concussion symptoms are exacerbated 
by reproducible levels of physical exercise (Table 2).
Management of athletes with migraine headaches must be 
individualized. In our experience, some patients with new onset 
or worsening migraine headaches following SRC can be success-
fully treated with sub-maximal aerobic exercise prescription while 
some experience an incomplete response with this form of treat-
ment (see footnote text 2). In these later cases, pharmacological 
management is often indicated and commonly includes the use 
of prophylactic medications such as tricyclic anti-depressants, 
beta-blockers, and anti-convulsants, symptomatic medications 
such as ibuprofen and acetaminophen and abortive medications 
such as triptans (113–115).
At present, there are no evidence-based guidelines to direct 
return-to-play decision-making in patients that have developed 
new onset migraine headaches or worsening migraines that have 
required pharmacological intervention. Because medications 
can mask headaches and other concussion-related symptoms, 
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a multi-disciplinary approach to medical clearance including 
graded aerobic treadmill testing and formal neuropsychological 
testing is strongly advised in these patients.
post-injury psychiatric outcomes
Another group of unique PCS patients that requires a multi-dis-
ciplinary approach is that presenting with primarily persistent 
emotional symptoms. Emotional symptoms such as sadness or 
depressed mood, nervousness or anxiety, irritability, fatigue, 
and difficulty sleeping are commonly reported among athletes 
following SRC and often resolve spontaneously along with other 
concussion symptoms with conservative  management (116). 
However, in some cases, these symptoms can persist and lead 
to the development of post-injury psychiatric outcomes includ-
ing novel post-injury psychiatric disorders, isolated suicidal 
ideation, or worsening symptoms of a pre-injury psychiatric 
disorder (84). Although the development of post-injury psychi-
atric outcomes following SRC is undoubtedly multi-factorial in 
etiology and impacted by individual pre-injury and post-injury 
factors, very few studies have examined these relationships 
in athletes with SRC (117–119). In one retrospective study 
of pediatric SRC patients presenting to a tertiary concussion 
program, post-injury psychiatric disorders were observed in 
11% of patients and were more common among those that 
were female, had a pre-injury or family history of psychiatric 
illness, and who endorsed a greater burden of overall and 
emotional concussion-related symptoms at initial presentation 
(84). Given the complex nature of these cases, athletes with 
PCS and prominent mood-related symptoms should be man-
aged by a multi-disciplinary team of healthcare professionals 
with clinical training and experience in TBI and psychiatry. A 
comprehensive clinical interview that provides an assessment 
of pre- and post-injury cognitive and mood-related functioning 
and incorporates validated age-appropriate clinical measures 
that screen for mood and psychiatric disorders is recommended 
for this population (120). Physicians should also screen for 
the use of alcohol and drugs that can precipitate, exacerbate, 
or prolong emotional symptoms of concussion. Overall, the 
pathophysiology of post-traumatic psychiatric outcomes 
remains poorly understood but may be mediated by a combina-
tion of pre-existing psychosocial factors as well as alterations 
in cerebral metabolism, neurotransmitter availability, and CBF 
(121–124).
The management of these athletes must be individualized 
and should take into consideration the impact of affective 
symptoms on social, school, and sports activities. Some patients 
may experience a symptom-limited threshold on graded aerobic 
exercise testing and benefit from sub-maximal exercise prescrip-
tion and re-introduction of sports-specific activities. However, 
some patients may not achieve a symptom-limited response on 
graded aerobic treadmill testing or may experience an incomplete 
response to sub-maximal exercise. In these cases, a multi-modal 
approach employing pharmacological and behavioral interven-
tions as well as close follow-up with a psychiatrist is recom-
mended. Importantly, because of the extensive overlap between 
the clinical manifestations of PCS and pre- and post-injury 
mood disorders, we recommend a multi-disciplinary approach 
to medical clearance and return-to-play decision-making in this 
patient population (64).
FUtUre direCtions
As illustrated in this report, significant advances in basic science, 
neuroimaging, exercise science, and clinical research have broad-
ened our understanding of the heterogeneous pathophysiological 
processes responsible for the clinical manifestations of PCS. 
Despite this progress, a number of persistent key questions and 
knowledge gaps remain to be addressed. In the future, clinicians 
caring for athletes with PCS would benefit from research aimed 
at addressing the following questions:
• What is the natural history of autonomic nervous system, 
cardiovascular, and CBF alterations in patients with acute SRC 
and physiological PCD?
• What tools can be used in the clinical setting to measure auto-
nomic nervous system, cardiovascular, and CBF dysfunction 
in PCS patients and help confirm physiological recovery of 
these parameters?
• What is the ideal timeframe to undertake graded aerobic 
treadmill testing and initiate sub-maximal aerobic exercise 
treatment following acute SRC?
• What is the natural history of vestibulo-ocular dysfunction 
following acute SRC and what are the evidence-based clinical 
indications for vestibular and vision therapy?
• What are the ideal clinical tools to assess central and peripheral 
pathophysiological mechanisms responsible for vestibulo-oc-
ular dysfunction in acute SRC and PCS patients?
• Does targeted vestibular and vision therapy lead to enhanced 
recovery of the subjective and objective manifestations of per-
sistent vestibulo-ocular symptoms compared to conservative 
management?
• What is the natural history or behavior of migraine headaches 
following SRC?
• What is the effect of sub-maximal exercise treatment and 
pharmacological intervention on the pathophysiological 
mechanisms governing post-traumatic migraine headaches?
• What are the biological, psychological, and social contributors 
to mental health-related outcomes following SRC?
• How does patient age impact the timing of multi-disciplinary 
active rehabilitation following acute SRC and PCS?
• What is the ideal multi-disciplinary approach to confirming 
neurocognitive and physiological recovery in athletes with 
PCS?
• What are the qualified roles and responsibilities of specific 
healthcare providers in the management of athletes who pres-
ent with prolonged clinical manifestations of SRC and TBI?
• What are the clinical indications to advise athletes to retire 
from future contact and collision sports in the setting of mul-
tiple concussions or prolonged recovery?
ConCLUsion
Athletes who present with persistent concussion symptoms and 
PCS represent a challenging patient population whose care must 
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be individualized and is best carried out by a multi-disciplinary 
team of experts with clinical training and experience in TBI. 
Using the evolving clinical approach presented here, features of 
the clinical history and physical examination, and results from 
graded aerobic treadmill testing can be used to identify the unique 
and often overlapping pathophysiological mechanisms governing 
persistent symptoms and help formulate targeted rehabilitation 
programs that promote clinical recovery and return to sports. 
Future prospective studies employing multi-modal laboratory 
and neuroimaging techniques are needed to develop reliable 
biomarkers that can help identify the temporal profile of these 
pathophysiological mechanisms and confirm their recovery in the 
clinical setting. Work is also needed to identify the optimal period 
to initiate targeted rehabilitative therapies across age groups and 
establish empirical evidence to support these interventions.
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